1. Home
  2. LAW vs PRLD Comparison

LAW vs PRLD Comparison

Compare LAW & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

HOLD

Current Price

$3.97

Market Cap

274.2M

Sector

Technology

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$3.90

Market Cap

325.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAW
PRLD
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
274.2M
325.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
LAW
PRLD
Price
$3.97
$3.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$8.00
$5.67
AVG Volume (30 Days)
520.2K
365.7K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
22.58
23.21
EPS
N/A
N/A
Revenue
$156,849,000.00
$12,140,000.00
Revenue This Year
$11.23
$320.10
Revenue Next Year
$10.60
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
8.29
73.43
52 Week Low
$2.45
$0.75
52 Week High
$9.11
$5.54

Technical Indicators

Market Signals
Indicator
LAW
PRLD
Relative Strength Index (RSI) 50.85 40.52
Support Level $3.81 $1.14
Resistance Level $5.03 $4.10
Average True Range (ATR) 0.26 0.37
MACD 0.02 -0.10
Stochastic Oscillator 73.96 11.59

Price Performance

Historical Comparison
LAW
PRLD

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: